High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment

Hormones (Athens). 2012 Apr-Jun;11(2):178-88. doi: 10.14310/horm.2002.1345.

Abstract

Objective: The investigation of the relationship between high density lipoprotein (HDL) and adiponectin.

Design: Thirty-seven obese or overweight [body mass index ≥27 Kg/m(2)], hypertriglyceridemic patients underwent one of the following interventions for 3 months: 1) Low-calorie diet (n=19), 2) Low-calorie diet plus fenofibrate (n=18).

Results: Circulating total adiponectin did not change significantly in the low-calorie diet group. However, in the subgroup of patients whose high density lipoprotein cholesterol (HDL-C) decreased over the first month of diet, a statistically significant reduction of the circulating total adiponectin was observed (p=0.010), while in the subgroup of patients whose HDL-C increased over the latter 2 months of the diet, an increase in circulating total adiponectin over the 2 months was found (p=0.043). The percentage change of HDL-C over the first month of diet was positively correlated with the percentage change of circulating total adiponectin (r=0.579, p=0.019). The percentage change of HDL-C over the 3 months of diet was positively correlated with the percentage changes of circulating total adiponectin (r=0.527, p=0.030) and high molecular weight (HMW) adiponectin (r=0.524, p=0.031). The change in circulating total adiponectin over the first month of diet was positively correlated with the HDL-C at 1 month (r=0.606, p=0.013). The change in HMW adiponectin over the 3 months of diet was positively correlated with the HDL-C at 3 months (r=0.602, p=0.011). The percentage change of circulating HMW adiponectin over the first month of fenofibrate treatment was positively correlated with the percentage change of HDL-C (r=0.594, p=0.012).

Conclusions: HDL is positively correlated with the changes in circulating adiponectin during dietary and fenofibrate treatment.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood*
  • Adiponectin / metabolism
  • Adolescent
  • Adult
  • Aged
  • Body Mass Index
  • Cholesterol, HDL / metabolism*
  • Diet
  • Female
  • Fenofibrate / administration & dosage
  • Fenofibrate / pharmacology*
  • Humans
  • Hypertriglyceridemia
  • Hypolipidemic Agents / administration & dosage
  • Hypolipidemic Agents / pharmacology*
  • Male
  • Middle Aged
  • Molecular Weight

Substances

  • Adiponectin
  • Cholesterol, HDL
  • Hypolipidemic Agents
  • Fenofibrate